Muthu Vaduganathan
@mvaduganathan
Cardiologist & Trialist @BrighamWomens @harvardmed | AE @JACCJournals | Podcast #DontMissABeat & #HFinFocus | Disclosures: bit.ly/3icLqlg
ID: 888976053951180801
https://connects.catalyst.harvard.edu/Profiles/display/Person/108817 23-07-2017 04:16:22
6,6K Tweet
8,8K Followers
527 Following
From JAMA Cardiology: In this pooled analysis of PARADIGM-HF/PARAGON-HF RCTs, sacubitril/valsartan significantly reduced all-cause hospitalization in heart failure, particularly in pts with LVEF <60%, driven by decreased cardiopulmonary events. ja.ma/4e5zuhZ #ESCCongress
Pooled analysis of patients with HFpEF in STEP-HFpEF, SELECT, and FLOW Mikhail Kosiborod Saint Luke's Mid America Heart Institute Saint Luke's Muthu Vaduganathan
A review of 3 trials in persons with type 2 diabetes, demonstrated consistent cardiovascular and kidney benefits of GLP-1 receptor agonists regardless of SGLT2 inhibitor use Circulation ahajournals.org/doi/10.1161/CI… #T2D #heartdisease #heartfailure #CKD
Implementing Medical Therapy During Worsening #HeartFailure released at #ESCCongress and just published in #EHJ👉 bit.ly/4cMFoUg EHJ Editor-in-Chief Ankeet S. Bhatt, MD, MBA
“The risks of omission in #heartfailure management - speeding up the implementation of guideline-directed heart failure therapy” Stellar panel of experts - Carys Barton 💙🫀#25in25 #Freedomfromfailure Muthu Vaduganathan Steve Greene Gianluigi Savarese
New analysis from CANVAS and CREDENCE trials reveals a bidirectional relationship between CV events and #CKD progression in type 2 #diabetes bit.ly/3X747wK #ESCCongress #JACC #T2D #MACE Brendon Neuen Muthu Vaduganathan
Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in #T2DM jacc.org/doi/full/10.10… Brendon Neuen Muthu Vaduganathan JACC Journals #ESCCongress European Society of Cardiology
Implementing Medical Therapy During Worsening Heart Failure Ankeet S. Bhatt, MD, MBA Muthu Vaduganathan academic.oup.com/eurheartj/adva… #WHF #HeartFailure #ESCCongress European Society of Cardiology Journals European Society of Cardiology EJHF Editor-in-Chief
Beta-blocker use and outcomes in patients with #HeartFailure and mildly reduced and preserved ejection fraction released at #ESCCongress and just published in #EJHF👉 bit.ly/3Tbt2hr EJHF Editor-in-Chief Faiez ZANNAD
Loss of kidney function accelerates dramatically after HF, while atherosclerotic & HF risk increases 3-4 fold after CKD progression Highlighting epidemiological & therapeutic synergies between CKD & CV disease Cardio-kidney-metabolic #simpub for #ESCCongress in JACC Journals
What an incredible #ESCCongress - so much fantastic and practice changing science Our The George Institute for Global Health/Brigham and Women's Hospital Harvard Medical School publications on the intersection of heart failure & CKD featured in Nature Medicine, Circulation, JACC Journals, and The Lancet Public Health
#Sacubitril/valsartan reduces incident #anaemia and iron therapy utilization in heart failure: The #PARAGON-HF trial European Society of Cardiology Journals Muthu Vaduganathan Carolyn Lam Pardeep S Jhund scottdavidsolomon Full 📝 👇🏻 onlinelibrary.wiley.com/doi/full/10.10… Henry Han Amr Abdin Giuseppe Galati Marco Metra
Incredibly happy to see the primary results of our 2nd NUDGE trial published in Nature Medicine! In summary, we found that electronic nudges remained effective in increasing flu vacc rates when administered over consecutive seasons 💉 ⬆️ Tor Biering-Sørensen, MD, MSc, MPH, PhD Muthu Vaduganathan Ankeet S. Bhatt, MD, MBA